| http://www.w3.org/ns/prov#value | - This assay may be used to identify treatments that will modulate the macrophage foam cell degradation of the matrix, by enzymes such as cathepsin K and thus aid in the identification of novel treatments that will attenuate atherosclerotic plaque turnover and subsequently prevent rupture of the unstable plaques.The measured cathepsin K activity, in form of the generated CTX-I fragment, may arise fr
|
